Zi-Lu Zhang, Xiao-Qian Xu, Qi Wen, Ruo-Xuan Zhang, Hong-Ru Chen, Min-Li Hu, Chupeng Zhang, Chuan-He Jiang, Lu-Xiang Wang, Jia-Yu Huang, Zeng-Kai Pan, Hua Jin, Yanmin Zhao, Wei Shi, Yang Cao, Xiaodong Mo, Xiao-Xia Hu (2026). Impacts of IPSS-M and transplant conditioning intensity in allogeneic stem cell transplant for myelodysplastic neoplasms. Bone Marrow Transplantation.DOI
Hong-Ru Chen, Xiaodong Mo (2026). Current status, development and challenges in the treatment of chronic graft-versus-host disease. Medical Review.DOI
Wenxuan Huo, Chuan-He Jiang, Cong-Xiao Zhang, Zhen Shang, Miao-Miao Zhao, J. Lai, Ying T. Chang, Jiong Hu, Ling Wang, Yu Wang, Yang Yang, Chun Wang, Chu-Xian Zhao, Yiqun Yu, Ling-Hui Xia, Hua Jin, Wei Shi, Yang Cao, Yanmin Zhao, Jia Chen, Xiao-Xia Hu, Xiaodong Mo (2026). Alternative donors, particularly haploidentical donors, are safe and effective for elderly patients with adverse-risk AML: a multicenter TROPHY study. Blood Cancer Journal.DOI
S. Tan, Chacko Joseph, M. L. Sobah, A. Chalk, Kelli Schleibs, Samuel C. Lee, G. Tjin, S. Chugh, Xiaodong Mo, Clea Grace, Jia Q Truong, Monique F. Smeets, K. Rice, M. Parker, Ashwin Unnikrishnan, A. Kulasekararaj, G. Mufti, M. Tobiasson, E. Hellström-Lindberg, J. Pimanda, L. Gudas, Davis J. McCarthy, J. Holien, Carl R. Walkley, M. Wall, L. Purton (2026). Dysregulated expression of Hoxa1 isoforms in hematopoietic stem and progenitor cells causes myelodysplastic syndromes. bioRxiv.DOI
Yilei Ma, Le-Qing Cao, Feng-Rong Wang, Hui Sun, Xiaodong Mo (2026). HHV-7 encephalitis following allogeneic hematopoietic stem cell transplantation: A case report and literature review. Cell Transplantation.DOI
Yuqi Ma, Tian-Yi Wang, Weihua Meng, Hong-Ru Chen, Fajin Tao, Q. Lu, Lin An, Xiaodong Mo, Gen Yang (2026). Patient-Level Diagnosis of Acute Myeloid Leukemia via Deep Learning Analysis of Bone Marrow Smear. arXiv.org.DOI
Le-Qing Cao, Yi Xia, Song Xue, Jian-Ping Zhang, Jiameng Li, Yue-Wen Wang, Qi Wen, Ze Tian, Jun Kong, Dao-Xing Deng, Xiao-Hui Zhang, Yang Cao, Na Xu, Xiaodong Mo (2026). Safety and Efficacy of Vedolizumab for the Patients With Gastrointestinal Acute Graft‐Versus‐Host Disease Refractory to Steroid Treatment After Allogeneic Hematopoietic Stem Cell Transplantation: A Real‐World, Retrospective Multicenter Study (VAST Study). MedComm.DOI
Xiaodong Mo, Xue-Jun Zhang, Rong Guo, E. Jiang, Jie-Jing Qian, Xiao-Yu Zhu, Jia Wei, Shun-Qing Wang, Zhong-Ming Zhang, Zhuo-Gang Liu, Yuxian Huang, Zhiguo Wang, Xiaoyuan Dong, Hai Yi, Ying Li, Dong Chai, Wei-Lan Wang, Weiting Zhong, Guoping Dong, Xiao-Jun Huang (2026). Novel highly selective ROCK2 inhibitor (TDI01) for the treatment of chronic graft-versus-host disease: a multicenter, open-label phase Ib/II study. Signal Transduction and Targeted Therapy.DOI
Xue-Lin Dou, Ruixia Liu, Yang Liu, N. Peng, L. Wen, Dao-Xing Deng, Le-Qing Cao, Qian Li, Li-Ru Wang, Feng-Rong Wang, Xiaodong Mo, Jin Lu (2025). Macrofocal multiple myeloma in the era of novel agents in China. Therapeutic Advances in Hematology.DOI
Jia-Yu Huang, Yi Xia, Meng-Qi Xiang, Ran Zhang, Yang Yang, Hong-Ru Chen, Changwei Dong, Su Li, Jun Zhu, Cheng-Wei Jin, Lu-Xiang Wang, Chuan-He Jiang, Wenxuan Huo, Zeng-Kai Pan, Yilei Ma, Hai-Yang Lu, Ze Tian, Zi-Lu Zhang, Jian-Ping Zhang, Chen Chen, Wei-Jie Cao, Wei Shi, Yanmin Zhao, Jia Chen, Yang Cao, Xiaodong Mo, Xiao-Xia Hu (2025). Acute myeloid leukemia patients with myelodysplasia-related gene mutations benefit from post-transplant hypomethylating agent maintenance. Transplantation and Cellular Therapy.DOI
Yang Liu, Danyang Shao, Ying T. Chang, Ya-Zhe Wang, Xue-Lin Dou, Nan Peng, Lei Wen, Feng-Rong Wang, Xiao-Jun Huang, Xiaodong Mo, Jin Lu (2025). Minimal clonal plasma cell contamination of peripheral stem cell grafts have an adverse prognostic impact in patients with multiple myeloma undergoing autologous transplantation. Acta Haematologica.DOI
Hai-Yang Lu, Yue-Wen Wang, Xiaodong Mo, Xiaoxia Hu (2025). Balancing cGVHD and GVL with Axatilimab: A macrophage-targeted strategy in allogeneic transplantation. The Innovation Medicine.DOI
Yue-Wen Wang, Wei-Ping Liu, Z. Gu, Yu Chang, Chunli Zhang, Yang Cao, Hai-Yang Lu, Xiaodan Liu, K. Lu, Jin Lu, Feng-Rong Wang, Lu-Xiang Wang, Shen-Miao Yang, Chuan-He Jiang, Chuan Li, Ming-Zhi Zhang, Xiao-Jun Huang, Xiao-Yu Zhu, Xiao-Jin Wu, Xiao-Xia Hu, Xiaodong Mo, Dai-Hong Liu (2025). Allogeneic versus autologous hematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: a real-world multicenter analysis in China. Cancer Letters.DOI
Xing Chen, Ruo-Xuan Zhang, Liang Huang, Xiaodong Mo, Xiao-Xia Hu, Yang Cao (2025). Impact of induction response and co-mutations on transplant outcomes in AML with myelodysplasia-related gene mutations: A multicenter retrospective study. Blood.DOI
Xue-Lin Dou, Juan Ren, Jiangtao Li, Xiaodan Liu, Li Bao, Yuan Chen, Peng Zhao, Yu-Ping Zhong, N. Peng, L. Wen, Le-Qing Cao, Yang Liu, Dao-Xing Deng, Feng-Rong Wang, Li-Ru Wang, Hui Liu, Xiao-Jun Huang, Xiaodong Mo, Jin Lu (2025). Tandem Versus Single Autologous Stem Cell Transplantation for High‐Risk Multiple Myeloma in the Era of Novel Agents: A Real‐World Study of China. Cancer Medicine.DOI
Jun Kong, Bin Chen, Yilei Ma, Lin An, Yao Lu, Nan Chen, Xiaodong Mo (2025). Greater Efficacy of Cidofovir Than of Foscarnet for the Treatment of Acyclovir-Resistant Herpes Simplex Virus Infection After Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Blood Medicine.DOI
Jiangtao Li, Wenxuan Huo, Yang Yang, Chunli Zhang, Feng-Rong Wang, Shengye Lu, Ru Feng, Yang Liu, Le-Qing Cao, Gao-Xiang Wang, Hui Liu, Ji-Hao Zhou, Yang Cao, Xiaodong Mo (2025). Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs. Cell Transplantation.DOI
Shuang Fan, Yang Yang, Shengye Lu, Jia-Yu Huang, Xiao-Su Zhao, Yang Cao, Xiaodong Mo, Xiao-Xia Hu (2025). DEK-NUP214 monitoring before and after allogeneic haematopoietic stem cell transplantation for acute myeloid leukemia: A report from the TROPHY study group. Journal of Translational Internal Medicine.DOI
Ting Wang, Yi Xia, Wei Hu, Bo-Ning Liu, Xiao-Hui Zhang, Wenxuan Huo, Jun Kong, Ya-Ru Ma, Wenwen Xiao, Ce Shi, Qixin Du, Le-Qing Cao, D. Han, Dongyue Yao, Hong-Ming Yin, Dao-Xing Deng, Jing-Yu Gao, Ya-Shu Jia, Jia-Ting Wang, Jing Liu, Xiaoshuang Han, Jun-Xia Wang, Ling Ma, Yun-Jing Xia, Shan-Shan Hu, Yuan-Yuan Zhang, Feng-Mei Zheng, Xiao-Jun Huang, Xiaodong Mo (2025). Comparison of plasma sterilizer and conventional laminar flow room in allogeneic hematopoietic stem cell transplant recipients. Cell Transplantation.DOI
Le-Qing Cao, Xiaodong Mo（2024）. 异基因造血干细胞移植治疗难治/复发弥漫大B细胞淋巴瘤的作用及其进展. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.DOI
Xiaodan Liu, Le-Qing Cao, Xinyi Wu, Xiaodong Mo (2024). Vedolizumab provides a new hope of acute graft-versus-host disease prophylaxis through immune regulation. The Innovation Medicine.DOI